SEC Filing Summary: Lion Biotechnologies, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Lion Biotechnologies, Inc. on June 8, 2016. The filing reports a corporate governance event regarding the rescheduling of the company's 2016 Annual Meeting of Stockholders. Note: The input metadata references "IOVANCE BIOTHERAPEUTICS, INC.", but the filing text explicitly identifies the registrant as Lion Biotechnologies, Inc.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report focused solely on a corporate event.
Material Changes
The Board of Directors determined to reschedule the 2016 Annual Meeting of Stockholders, which was originally set for Friday, June 10, 2016. No financial material changes are reported in this document.
Guidance, Outlook, and Risks
The filing includes no management commentary on financial outlook, guidance, risks, or contingencies. The only disclosed event is the postponement of the shareholder meeting, with a press release attached as Exhibit 99.1.
Key Facts for Investor Verification
- Verify the new date and time for the rescheduled 2016 Annual Meeting of Stockholders.
- Confirm the reason for the rescheduling by reviewing the attached press release (Exhibit 99.1).
- Ensure the registrant name is Lion Biotechnologies, Inc., not IOVANCE BIOTHERAPEUTICS, INC.